Clinical Trial Update: Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function [Phase 1]

View source ↗

Summary

Phase 1 trial assessing lymphodepleting total body irradiation plus cyclophosphamide before Carvykti (cilta-cel) CAR-T therapy in multiple myeloma patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Carvykti (ciltacabtagene autoleucel)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Multiple Myeloma | Phase 1 | Status: RECRUITING